Brave Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-50,817
| Closed | -$490K | – | 156 |
|
|
2020
Q4 | $490K | Hold |
50,817
| – | – | 0.19% | 63 |
|
|
2020
Q3 | $458K | Buy |
+50,817
| New | +$458K | 0.22% | 57 |
|
|
2020
Q1 | – | Sell |
-4,317
| Closed | -$42K | – | 150 |
|
|
2019
Q4 | $42K | Buy |
+4,317
| New | +$42K | 0.02% | 147 |
|
|
2019
Q3 | – | Sell |
-14,852
| Closed | -$137K | – | 158 |
|
|
2019
Q2 | $137K | Buy |
+14,852
| New | +$137K | 0.08% | 131 |
|
|
2016
Q4 | – | Sell |
-4,917
| Closed | -$226K | – | 311 |
|
|
2016
Q3 | $226K | Sell |
4,917
-3,750
| -43% | -$172K | 0.14% | 117 |
|
|
2016
Q2 | $435K | Buy |
8,667
+2,925
| +51% | +$147K | 0.29% | 79 |
|
|
2016
Q1 | $307K | Hold |
5,742
| – | – | 0.22% | 99 |
|
|
2015
Q4 | $377K | Sell |
5,742
-1,200
| -17% | -$78.8K | 0.25% | 92 |
|
|
2015
Q3 | $392K | Sell |
6,942
-550
| -7% | -$31.1K | 0.3% | 85 |
|
|
2015
Q2 | $443K | Hold |
7,492
| – | – | 0.31% | 86 |
|
|
2015
Q1 | $467K | Hold |
7,492
| – | – | 0.33% | 79 |
|
|
2014
Q4 | $431K | Buy |
7,492
+242
| +3% | +$13.9K | 0.31% | 85 |
|
|
2014
Q3 | $390K | Sell |
7,250
-400
| -5% | -$21.5K | 0.29% | 92 |
|
|
2014
Q2 | $401K | Hold |
7,650
| – | – | 0.28% | 99 |
|
|
2014
Q1 | $404K | Sell |
7,650
-300
| -4% | -$15.8K | 0.32% | 86 |
|
|
2013
Q4 | $319K | Buy |
+7,950
| New | +$319K | 0.26% | 93 |
|